mRNA Revolution: a new generation of medicine - updated for 2024
This report from the BIA, alongside CPI and Cytiva, highlights the critical role the UK is playing in the field of mRNA research. The UK's position as a global leader in the field of mRNA technology is outlined, alongside the opportunities the technology presents and the challenges which still have to be overcome.
Featuring case studies from Moderna;SiSaf, eXmoor, Touchlight, New England Biolabs and TriLink, read the report to gain an in-depth overview of the history and journey of mRNA from its discovery in 1961 to today and to see a visualised map of the diverse range of companies contributing to the UK’s mRNA ecosystem.
Other significant findings of the report:
- mRNA has the potential to revolutionise the way we treat diseases
- A solution must be found for the problems inherent to manufacturing mRNA on a large scale
- mRNA technology is specialised in nature and this poses a particular problem, given the current skills shortage in the life sciences sector
